Filing Details

Accession Number:
0001562180-17-003065
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-29 18:23:07
Reporting Period:
2017-09-29
Accepted Time:
2017-09-29 18:23:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205014 J Gil Lunsen Van C/O Array Biopharma Inc.
3200 Walnut Street
Boulder CO 80301
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-29 45,000 $10.58 55,260 No 4 M Direct
Common Stock Disposition 2017-09-29 39,928 $12.36 15,332 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2017-09-29 45,000 $0.00 45,000 $10.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-11-01 2017-11-01 No 4 M Direct
Footnotes
  1. This Form 4 is reporting the exercise by the reporting person of an option scheduled to expire on November 1, 2017 and the sale of a portion of the option shares to satisfy payment of the option exercise price.
  2. The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
  3. The option vested in 3 equal annual installments beginning on November 1, 2008.